Stocks
Cassava Sciences Inc (SAVA) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -32.3 | -78.7 | -104.4 | -141.1 | -94.5 | -73.1 | ||
| Changes by years, y/y, % | +412% | +143% | +33% | +35% | -33% | +71.8% | |||
Cassava Sciences Inc. EBITDA US GAAP, bln rub
Cassava Sciences Inc. EBITDA US GAAP, changes, %
Cassava Sciences Inc. EBITDA US GAAP, sum by quarters, bln rub
Cassava Sciences Inc (SAVA) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -21.4 | -13.9 | -10.6 | -48.6 | 0.000 | -73.1 | |
| Changes by years, y/y, % | -6% | -79% | -66% | +151% | -100% | |||
| Changes by quarters, q/q, % | +11% | -35% | -24% | +358% | -100% | |||
